These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15851341)

  • 41. Clinical evaluation of defibrillation efficacy with a new single-capacitor biphasic waveform in patients undergoing implantation of an implantable cardioverter defibrillator.
    Brugada J; Herse B; Sandsted B; Michel U; Schubert BD; Hahn SJ
    Europace; 2001 Oct; 3(4):278-84. PubMed ID: 11678385
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of rapid biphasic shock subpulse switching on ventricular defibrillation thresholds.
    Dosdall DJ; Rothe DE; Brandon TA; Sweeney JD
    J Cardiovasc Electrophysiol; 2004 Jul; 15(7):802-8. PubMed ID: 15250866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it?
    Calvi V; Dugo D; Capodanno D; Arancio R; Di Grazia A; Liotta C; Puzzangara E; Ragusa A; Arestia A; Tamburino C
    Am Heart J; 2010 Jan; 159(1):98-102. PubMed ID: 20102873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of biphasic shock duration on defibrillation threshold with different electrode configurations and phase 2 capacitances: prediction by upper-limit-of-vulnerability determination.
    Schauerte PN; Ziegert K; Waldmann M; Schöndube FA; Birkenhauer F; Mischke K; Grossmann M; Hanrath P; Stellbrink C
    Circulation; 1999 Mar; 99(11):1516-22. PubMed ID: 10086978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of waveform tilt on defibrillation thresholds in humans.
    Shorofsky SR; Foster AH; Gold MR
    J Cardiovasc Electrophysiol; 1997 May; 8(5):496-501. PubMed ID: 9160225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of upper limit of vulnerability and defibrillation probability of success curves using a nonthoracotomy lead system.
    Souza JJ; Malkin RA; Ideker RE
    Circulation; 1995 Feb; 91(4):1247-52. PubMed ID: 7850965
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs.
    Swerdlow CD; Shehata M; Chen PS
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):258-70. PubMed ID: 17338725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Defibrillation waveform duration adjustment increases the proportion of acceptable defibrillation thresholds in patients implanted with single-coil defibrillation leads.
    Gabriels J; Budzikowski AS; Kassotis JT
    Cardiology; 2013; 124(2):71-5. PubMed ID: 23363780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Upper limit of vulnerability predicts chronic defibrillation threshold for transvenous implantable defibrillators.
    Martin DJ; Chen PS; Hwang C; Gang ES; Mandel WJ; Peter CT; Swerdlow CD
    J Cardiovasc Electrophysiol; 1997 Mar; 8(3):241-8. PubMed ID: 9083873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective randomized comparison of two defibrillation safety margins in unipolar, active pectoral defibrillator therapy.
    Carlsson J; Schulte B; Erdogan A; Sperzel J; Güttler N; Schwarz T; Pitschner HF; Neuzner J
    Pacing Clin Electrophysiol; 2003 Feb; 26(2 Pt 1):613-8. PubMed ID: 12710322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discrepancies between the upper limit of vulnerability and defibrillation threshold: prevalence and clinical predictors.
    Gurevitz OT; Friedman PA; Glikson M; Trusty JM; Ballman KV; Rosales AG; Hayes DL; Hammill SC; Swerdlow CD
    J Cardiovasc Electrophysiol; 2003 Jul; 14(7):728-32. PubMed ID: 12930253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-tilt monophasic and biphasic waveforms compared with standard biphasic waveforms in the transvenous defibrillation of ventricular fibrillation.
    Bennett JR; Darragh KM; Walsh SJ; Allen DJ; Scott M; Stevenson M; Adgey JA; Anderson JM; Manoharan G
    Pacing Clin Electrophysiol; 2014 Mar; 37(3):279-89. PubMed ID: 24102186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Porcine defibrillation thresholds with chopped biphasic truncated exponential waveforms.
    Sullivan JL; Melnick SB; Chapman FW; Walcott GP
    Resuscitation; 2007 Aug; 74(2):325-31. PubMed ID: 17383792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators.
    Swerdlow CD; Ahern T; Kass RM; Davie S; Mandel WJ; Chen PS
    J Am Coll Cardiol; 1996 Apr; 27(5):1112-8. PubMed ID: 8609329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of shock waveform configuration on the defibrillation capacity of implantable cardioverter defibrillators in dogs.
    Pariaut R; Saelinger C; Vila J; Deforge W; Queiroz-Williams P; Beaufrère H; Zimmerman M; Saile K; Reynolds CA
    J Vet Cardiol; 2012 Sep; 14(3):389-98. PubMed ID: 22819488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of rapid pacing and T-wave scanning on the relation between the defibrillation and upper-limit-of-vulnerability dose-response curves.
    Malkin RA; Idriss SF; Walker RG; Ideker RE
    Circulation; 1995 Sep; 92(5):1291-9. PubMed ID: 7648678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of successful defibrillation threshold test during CRT-D implantation.
    Przybylski A; Oreziak A; Lewandowski Z; Hasiec A; Orczykowski M; Walczak F
    Kardiol Pol; 2010 May; 68(5):512-8. PubMed ID: 20491010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ascending Defibrillation Waveform Significantly Reduces Myocardial Morphological Damage and Injury Current.
    Huang J; Ruse RB; Walcott GP; Litovsky S; Bohanan SJ; Gong DW; Kroll MW
    JACC Clin Electrophysiol; 2019 Jul; 5(7):854-862. PubMed ID: 31320015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of an active abdominal pulse generator on defibrillation thresholds with a dual-coil, transvenous ICD lead system.
    Rashba EJ; Farasat M; Kirk MM; Shorofsky SR; Peters RW; Gold MR
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):617-20. PubMed ID: 16836709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.